NO930032L - Doseringsform for administrering av et medikament for aa frembringe circadian terapi - Google Patents

Doseringsform for administrering av et medikament for aa frembringe circadian terapi

Info

Publication number: NO930032L
Authority: NO; Norway
Prior art keywords: administrating; medicine; making; dosage form; circadian
Prior art date: 1990-07-12

Application number

NO93930032A

Other languages

English (en)

Norwegian (no)

Other versions

NO930032D0 (no

Inventor

Patrick S-L Wong

Frank Jao

Felix Theeuwes

Andrew Lam

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-07-12

Filing date

1993-01-07

Publication date

1993-01-15

1993-01-07 Application filed by Alza Corp filed Critical Alza Corp

1993-01-07 Publication of NO930032D0 publication Critical patent/NO930032D0/no

1993-01-15 Publication of NO930032L publication Critical patent/NO930032L/no

Links

230000002060 circadian Effects 0.000 title 1
239000002552 dosage form Substances 0.000 title 1
238000002560 therapeutic procedure Methods 0.000 title 1
239000003814 drug Substances 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
230000001934 delay Effects 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
External Artificial Organs (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO93930032A 1990-07-12 1993-01-07 Doseringsform for administrering av et medikament for aa frembringe circadian terapi NO930032L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55181990A	1990-07-12	1990-07-12
PCT/US1991/004810 WO1992000729A1 (fr)	1990-07-12	1991-07-08	Forme de dosage pour l'administration d'un medicament en vue d'une therapie circadienne

Publications (2)

Publication Number	Publication Date
NO930032D0 NO930032D0 (no)	1993-01-07
NO930032L true NO930032L (no)	1993-01-15

Family

ID=24202810

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO93930032A NO930032L (no)	1990-07-12	1993-01-07	Doseringsform for administrering av et medikament for aa frembringe circadian terapi

Country Status (16)

Country	Link
EP (1)	EP0538335B1 (fr)
JP (1)	JP2948906B2 (fr)
AT (1)	ATE116845T1 (fr)
AU (1)	AU652169B2 (fr)
CA (1)	CA2046448C (fr)
DE (1)	DE69106709T2 (fr)
DK (1)	DK0538335T3 (fr)
ES (1)	ES2069897T3 (fr)
FI (1)	FI930097A7 (fr)
IE (1)	IE62720B1 (fr)
MX (1)	MX9100118A (fr)
NO (1)	NO930032L (fr)
NZ (1)	NZ238867A (fr)
PT (1)	PT98252B (fr)
WO (1)	WO1992000729A1 (fr)
ZA (1)	ZA915274B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5156850A (en) *	1990-08-31	1992-10-20	Alza Corporation	Dosage form for time-varying patterns of drug delivery
UA74141C2 (uk)	1998-12-09	2005-11-15	Дж.Д. Сірл Енд Ко.	Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
ES2325209T3 (es) *	2002-07-31	2009-08-28	Phafag Aktiengesellschaft	Formulacion farmaceutica y su uso en el tratamiento de enfermedades del oido interno.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4327725A (en) *	1980-11-25	1982-05-04	Alza Corporation	Osmotic device with hydrogel driving member
NZ206600A (en) *	1983-05-11	1987-01-23	Alza Corp	Osmotic drug delivery device
US4765989A (en) *	1983-05-11	1988-08-23	Alza Corporation	Osmotic device for administering certain drugs
US4753802A (en) *	1986-03-19	1988-06-28	Alza Corporation	Verapamil dosage form
US4716496A (en) *	1986-05-09	1987-12-29	Eaton Corporation	Panel-mounted control station housing
US4847093A (en) *	1986-06-19	1989-07-11	Alza Corporation	Dosage form with means for governing rate of gas formation
ES2054333T3 (es) *	1989-01-30	1994-08-01	Alza Corp	Forma de dosificacion para administrar un antagonista del calcio.
JP2885858B2 (ja) *	1989-01-31	1999-04-26	イー・ペー・アー・インテルナチオナーレ・ファルマ・アゲンチュル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	有効物質の制御放出システムおよびその製造方法

1991
- 1991-06-08 NZ NZ238867A patent/NZ238867A/xx unknown
- 1991-07-08 EP EP91912826A patent/EP0538335B1/fr not_active Expired - Lifetime
- 1991-07-08 DK DK91912826.4T patent/DK0538335T3/da active
- 1991-07-08 AU AU82047/91A patent/AU652169B2/en not_active Ceased
- 1991-07-08 IE IE237391A patent/IE62720B1/en not_active IP Right Cessation
- 1991-07-08 ZA ZA915274A patent/ZA915274B/xx unknown
- 1991-07-08 ES ES91912826T patent/ES2069897T3/es not_active Expired - Lifetime
- 1991-07-08 DE DE69106709T patent/DE69106709T2/de not_active Expired - Fee Related
- 1991-07-08 CA CA002046448A patent/CA2046448C/fr not_active Expired - Fee Related
- 1991-07-08 JP JP3512125A patent/JP2948906B2/ja not_active Expired - Fee Related
- 1991-07-08 FI FI930097A patent/FI930097A7/fi not_active Application Discontinuation
- 1991-07-08 MX MX9100118A patent/MX9100118A/es not_active IP Right Cessation
- 1991-07-08 WO PCT/US1991/004810 patent/WO1992000729A1/fr not_active Ceased
- 1991-07-08 PT PT98252A patent/PT98252B/pt not_active IP Right Cessation
- 1991-07-08 AT AT91912826T patent/ATE116845T1/de not_active IP Right Cessation
1993
- 1993-01-07 NO NO93930032A patent/NO930032L/no unknown

Also Published As

Publication number	Publication date
ATE116845T1 (de)	1995-01-15
DE69106709T2 (de)	1995-05-11
NZ238867A (en)	1993-08-26
CA2046448C (fr)	2006-05-02
JP2948906B2 (ja)	1999-09-13
FI930097A0 (fi)	1993-01-11
FI930097L (fi)	1993-01-11
PT98252A (pt)	1992-05-29
NO930032D0 (no)	1993-01-07
ES2069897T3 (es)	1995-05-16
MX9100118A (es)	1992-09-01
ZA915274B (en)	1992-04-29
IE62720B1 (en)	1995-02-22
DE69106709D1 (de)	1995-02-23
AU652169B2 (en)	1994-08-18
AU8204791A (en)	1992-02-04
DK0538335T3 (da)	1995-06-19
CA2046448A1 (fr)	1992-01-13
WO1992000729A1 (fr)	1992-01-23
EP0538335B1 (fr)	1995-01-11
JPH05508844A (ja)	1993-12-09
EP0538335A1 (fr)	1993-04-28
FI930097A7 (fi)	1993-01-11
IE912373A1 (en)	1992-01-15
PT98252B (pt)	1998-12-31

Similar Documents

Publication	Publication Date	Title
NO923590L (no)	1992-11-23	Doseringsform for avgivelse av medikament til tarmen
NO306377B1 (no)	1999-11-01	Doseform for avgivelse av et medikament
NO924209L (no)	1992-11-09	Doseringsform for tilfoersel av et antiparkinsonmiddel
NO940376L (no)	1994-02-07	Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet
CY1112260T1 (el)	2015-12-09	Σκευασματα υδροκωδονης ελεγχομενης απελευθερωσης
ATE108657T1 (de)	1994-08-15	Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
SE8703034L (sv)	1988-02-08	Oralt terapeutiskt system med systemisk verkan
NO20055880L (no)	2005-12-28	Memantin orale doseringsformer
ATE215816T1 (de)	2002-04-15	Feste oral anzuwendende arzeneiform
ES2188782T3 (es)	2003-07-01	Formulaciones farmaceuticas que contienen darifenacina.
ATE427103T1 (de)	2009-04-15	Orale verabreichung von adenosin analogen
ES2117642T3 (es)	1998-08-16	Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
ATE100708T1 (de)	1994-02-15	Unbeschichtete pharmazeutische reaktionstablette.
DK239782A (da)	1982-12-05	Kapsler indeholdende det aktive princip i et allergen og fremgangsmaade til fremstilling deraf
BR9709838A (pt)	1999-08-10	Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
NO20101070L (no)	2001-02-05	Fremgangsmate til dosering av et medikament, samt doseringsform
NO923397L (no)	1992-08-31	Avgivelsesanordning
NO930032L (no)	1993-01-15	Doseringsform for administrering av et medikament for aa frembringe circadian terapi
TR199801184T2 (xx)	1998-09-21	Analjezik tesirli yeni bile�ikler.
MY100780A (en)	1991-02-14	Azumolene dosage form.
DE69531166D1 (de)	2003-07-31	Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen
Jacknowitz et al.	1977	Nitrofurantoin polyneuropathy: report of two cases
SU906521A1 (ru)	1982-02-23	Способ предупреждени беременности
RU2000117903A (ru)	2002-06-27	Способ лечения хронического гастрита и язвенной болезни двенадцатиперстной кишки
Kulkarni et al.	1970	Effect of sodium bicarbonate on tolerance to orally administered iron